All patient guidesSemua panduan pasien返回全部指南
March 04, 2026 Patient guidePanduan pasien就医指南

Cancer Treatment in Beijing: A Guide for International PatientsCancer Treatment in Beijing: A Guide for International Patients北京癌症治疗:国际患者指南

Beijing stands as one of Asia's premier destinations for cancer treatment, combining national-level expertise, cutting-edge technologies, and affordable options that attract patients from around the world. In 2026, the city hosts leading on…Beijing stands as one of Asia's premier destinations for cancer treatment, combining national-level expertise, cutting-edge technologies, and affordable options that attract patients from around the world. In 2026, the city hosts leading on…北京是亚洲顶级癌症治疗目的地之一,结合了国家级的专业知识、尖端技术和吸引来自世界各地患者的实惠选择。到2026年,该市将拥有领先的肿瘤中心,处理大量复杂病例,参与全球临床试验,并快速获得创新疗法。

Beijing stands as one of Asia's premier destinations for cancer treatment, combining national-level expertise, cutting-edge technologies, and affordable options that attract patients from around the world. In 2026, the city hosts leading oncology centers with high volumes of complex cases, participation in global clinical trials, and rapid access to innovative therapies.

This guide provides an overview of major hospitals, advanced treatment capabilities, approximate costs for international patients, and key considerations to help you plan effectively.

Why International Patients Choose Beijing for Cancer Care

China's oncology sector has advanced rapidly, with Beijing concentrating top resources. Key advantages include:

  • Access to innovative treatments like CAR-T cell therapy (for blood cancers and emerging solid tumors), proton/heavy ion radiotherapy, and numerous clinical trials—often available sooner or at lower cost than in many countries.
  • High patient volumes that build deep specialist experience, particularly in common cancers such as lung, gastrointestinal, breast, and liver.
  • Costs typically 40–80% lower than in the US or Europe, while maintaining standards aligned with international guidelines (e.g., NCCN).
  • Dedicated services for foreigners in select hospitals, including English-speaking staff, visa support, and telemedicine follow-ups.

Many patients travel for second opinions, complex cases, or financial relief when facing long waits or high expenses at home.

Leading Oncology Hospitals in Beijing

Beijing features a mix of public flagship institutions and private/international-focused facilities.

  • Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center): Ranked as China's top oncology specialty hospital, it leads in lung, esophageal, breast, colorectal, gastrointestinal, hepatobiliary, pancreatic, and gynecological cancers. It handles complex and late-stage cases, sets national guidelines, and offers precision diagnostics.

  • Peking University Cancer Hospital (Beijing Cancer Hospital): A major academic center specializing in gastrointestinal cancers, breast cancer, lymphoma, melanoma, and hepatobiliary tumors. Known for multidisciplinary teams, minimally invasive surgeries, and international collaborations.

  • Peking Union Medical College Hospital: China's highest-ranked comprehensive hospital, ideal for rare tumors, neuroendocrine cancers, elderly patients, or those with comorbidities. It provides strong genetic counseling and integrated care.

  • Private and International-Oriented Options:

  • Yanda International Hospital: JCI-accredited, combining Western oncology with Traditional Chinese Medicine for holistic approaches.
  • Beijing GoBroad Boren Hospital: A leader in CAR-T therapy and hematologic cancers, with excellent English support and amenities for international patients.
  • Beijing Arion Cancer Hospital: Focused on advanced radiotherapy referrals and personalized services for foreigners.
  • Beijing Puhua International Hospital: Popular for immunotherapy and minimally invasive treatments with streamlined processes.

Public hospitals often handle high-volume expertise, while private ones prioritize comfort and language support.

Key Treatment Capabilities

Beijing's hospitals offer comprehensive, multidisciplinary care:

  • Multidisciplinary Teams (MDT): Experts from surgery, medical oncology, radiation, pathology, and genetics collaborate on personalized plans.
  • Precision Medicine: Routine NGS gene sequencing and targeted drug matching for lung, breast, colorectal, and other cancers.
  • Surgery: Robotic-assisted (Da Vinci), laparoscopic, and minimally invasive procedures for faster recovery.
  • Chemotherapy & Targeted Therapy: Affordable domestic options alongside international standards.
  • Immunotherapy: PD-1/PD-L1 inhibitors and combinations for advanced cases.
  • Advanced Radiotherapy: IMRT, SBRT, proton, and heavy ion therapy (precise for brain, spinal, and pediatric tumors).
  • CAR-T Cell Therapy: Widely available for blood cancers; emerging for solid tumors at specialized centers.
  • Integrative Approaches: Traditional Chinese Medicine to manage side effects and support recovery.
  • Clinical Trials: Extensive opportunities for novel therapies, often at reduced or no cost.

Estimated Costs for International Patients (USD, 2026)

Costs vary by cancer type, stage, hospital, and whether treatments are commercial or trial-based. International patients typically pay out-of-pocket or through global insurance. Estimates are approximate ranges for self-pay in private/international departments:

  • Initial Evaluation & Diagnostics: $2,000–$6,000 (consultations, PET-CT, biopsies, genetic testing).
  • Surgery: $5,000–$30,000+ (standard to complex/robotic-assisted).
  • Chemotherapy: $500–$3,000 per cycle; full course $5,000–$20,000.
  • Radiotherapy: $5,000–$25,000 (standard/advanced); proton/heavy ion full course $30,000–$60,000.
  • Targeted/Immunotherapy: Monthly $2,000–$8,000; annual $25,000–$60,000.
  • CAR-T Therapy: $60,000–$250,000 (blood cancers $120,000–$170,000 commercially; lower in trials).
  • Overall by Stage:
  • Early-stage (surgery + adjuvant): $7,000–$21,000.
  • Mid-stage comprehensive: $21,000–$42,000.
  • Advanced/maintenance (annual): $7,000–$21,000+.

Hospital stays add $20–$500 per day depending on ward type. Accommodation in Beijing ranges from $50–$150 per night (hotel) to $800–$2,000 monthly (apartment). Clinical trials can substantially reduce expenses.

These figures are significantly lower than equivalent care in many Western countries, but always request personalized quotes.

Practical Advice for Foreign Patients

  • Gather and translate medical records (scans, pathology, treatment history) for virtual consultations.
  • Secure a medical (S2) visa with hospital invitation letters.
  • Choose hospitals with international departments for better language and logistical support.
  • Budget for extras like translation, travel, and living expenses.
  • Consider insurance coverage or trial enrollment to manage costs.
  • Plan for follow-up via telemedicine.

Beijing provides high-quality, innovative cancer care with practical advantages for many international patients. Consult hospitals directly for the latest details and tailored plans. Wishing you strength and positive outcomes on your journey.

Beijing stands as one of Asia's premier destinations for cancer treatment, combining national-level expertise, cutting-edge technologies, and affordable options that attract patients from around the world. In 2026, the city hosts leading oncology centers with high volumes of complex cases, participation in global clinical trials, and rapid access to innovative therapies.

This guide provides an overview of major hospitals, advanced treatment capabilities, approximate costs for international patients, and key considerations to help you plan effectively.

Why International Patients Choose Beijing for Cancer Care

China's oncology sector has advanced rapidly, with Beijing concentrating top resources. Key advantages include:

  • Access to innovative treatments like CAR-T cell therapy (for blood cancers and emerging solid tumors), proton/heavy ion radiotherapy, and numerous clinical trials—often available sooner or at lower cost than in many countries.
  • High patient volumes that build deep specialist experience, particularly in common cancers such as lung, gastrointestinal, breast, and liver.
  • Costs typically 40–80% lower than in the US or Europe, while maintaining standards aligned with international guidelines (e.g., NCCN).
  • Dedicated services for foreigners in select hospitals, including English-speaking staff, visa support, and telemedicine follow-ups.

Many patients travel for second opinions, complex cases, or financial relief when facing long waits or high expenses at home.

Leading Oncology Hospitals in Beijing

Beijing features a mix of public flagship institutions and private/international-focused facilities.

  • Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center): Ranked as China's top oncology specialty hospital, it leads in lung, esophageal, breast, colorectal, gastrointestinal, hepatobiliary, pancreatic, and gynecological cancers. It handles complex and late-stage cases, sets national guidelines, and offers precision diagnostics.

  • Peking University Cancer Hospital (Beijing Cancer Hospital): A major academic center specializing in gastrointestinal cancers, breast cancer, lymphoma, melanoma, and hepatobiliary tumors. Known for multidisciplinary teams, minimally invasive surgeries, and international collaborations.

  • Peking Union Medical College Hospital: China's highest-ranked comprehensive hospital, ideal for rare tumors, neuroendocrine cancers, elderly patients, or those with comorbidities. It provides strong genetic counseling and integrated care.

  • Private and International-Oriented Options:

  • Yanda International Hospital: JCI-accredited, combining Western oncology with Traditional Chinese Medicine for holistic approaches.
  • Beijing GoBroad Boren Hospital: A leader in CAR-T therapy and hematologic cancers, with excellent English support and amenities for international patients.
  • Beijing Arion Cancer Hospital: Focused on advanced radiotherapy referrals and personalized services for foreigners.
  • Beijing Puhua International Hospital: Popular for immunotherapy and minimally invasive treatments with streamlined processes.

Public hospitals often handle high-volume expertise, while private ones prioritize comfort and language support.

Key Treatment Capabilities

Beijing's hospitals offer comprehensive, multidisciplinary care:

  • Multidisciplinary Teams (MDT): Experts from surgery, medical oncology, radiation, pathology, and genetics collaborate on personalized plans.
  • Precision Medicine: Routine NGS gene sequencing and targeted drug matching for lung, breast, colorectal, and other cancers.
  • Surgery: Robotic-assisted (Da Vinci), laparoscopic, and minimally invasive procedures for faster recovery.
  • Chemotherapy & Targeted Therapy: Affordable domestic options alongside international standards.
  • Immunotherapy: PD-1/PD-L1 inhibitors and combinations for advanced cases.
  • Advanced Radiotherapy: IMRT, SBRT, proton, and heavy ion therapy (precise for brain, spinal, and pediatric tumors).
  • CAR-T Cell Therapy: Widely available for blood cancers; emerging for solid tumors at specialized centers.
  • Integrative Approaches: Traditional Chinese Medicine to manage side effects and support recovery.
  • Clinical Trials: Extensive opportunities for novel therapies, often at reduced or no cost.

Estimated Costs for International Patients (USD, 2026)

Costs vary by cancer type, stage, hospital, and whether treatments are commercial or trial-based. International patients typically pay out-of-pocket or through global insurance. Estimates are approximate ranges for self-pay in private/international departments:

  • Initial Evaluation & Diagnostics: $2,000–$6,000 (consultations, PET-CT, biopsies, genetic testing).
  • Surgery: $5,000–$30,000+ (standard to complex/robotic-assisted).
  • Chemotherapy: $500–$3,000 per cycle; full course $5,000–$20,000.
  • Radiotherapy: $5,000–$25,000 (standard/advanced); proton/heavy ion full course $30,000–$60,000.
  • Targeted/Immunotherapy: Monthly $2,000–$8,000; annual $25,000–$60,000.
  • CAR-T Therapy: $60,000–$250,000 (blood cancers $120,000–$170,000 commercially; lower in trials).
  • Overall by Stage:
  • Early-stage (surgery + adjuvant): $7,000–$21,000.
  • Mid-stage comprehensive: $21,000–$42,000.
  • Advanced/maintenance (annual): $7,000–$21,000+.

Hospital stays add $20–$500 per day depending on ward type. Accommodation in Beijing ranges from $50–$150 per night (hotel) to $800–$2,000 monthly (apartment). Clinical trials can substantially reduce expenses.

These figures are significantly lower than equivalent care in many Western countries, but always request personalized quotes.

Practical Advice for Foreign Patients

  • Gather and translate medical records (scans, pathology, treatment history) for virtual consultations.
  • Secure a medical (S2) visa with hospital invitation letters.
  • Choose hospitals with international departments for better language and logistical support.
  • Budget for extras like translation, travel, and living expenses.
  • Consider insurance coverage or trial enrollment to manage costs.
  • Plan for follow-up via telemedicine.

Beijing provides high-quality, innovative cancer care with practical advantages for many international patients. Consult hospitals directly for the latest details and tailored plans. Wishing you strength and positive outcomes on your journey.

北京是亚洲顶级癌症治疗目的地之一,结合了国家级的专业知识、尖端技术和吸引来自世界各地患者的实惠选择。到2026年,该市将拥有领先的肿瘤中心,处理大量复杂病例,参与全球临床试验,并快速获得创新疗法。

本指南提供了主要医院、先进治疗能力、国际患者的近似费用以及帮助您有效规划的关键考虑因素的概述。

为什么国际患者选择北京进行癌症治疗

中国的肿瘤学领域迅速发展,北京集中顶级资源。主要优势包括:

  • 访问创新治疗,如CAR-T细胞疗法(用于血癌和新兴实体肿瘤)、质子/重离子放疗,以及众多临床试验——通常比许多国家更早或费用更低。
  • 高患者量积累了丰富的专业经验,特别是在肺癌、胃肠癌、乳腺癌和肝癌等常见癌症方面。
  • 费用通常比美国或欧洲低40%–80%,同时保持与国际指南(如NCCN)一致的标准。
  • 选定医院为外国人提供专门服务,包括讲英语的工作人员、签证支持和远程医疗跟进。

许多患者在面对长时间等待或高费用时,选择出国寻求第二意见、复杂病例或经济救助。

北京领先的肿瘤医院

北京拥有公共旗舰机构和私人/国际专注设施的混合。

  • 中国医学科学院肿瘤医院(国家癌症中心):被评为中国顶级肿瘤专科医院,在肺癌、食道癌、乳腺癌、结直肠癌、胃肠癌、肝胆癌、胰腺癌和妇科癌症方面处于领先地位。处理复杂和晚期病例,制定国家指南,并提供精准诊断。

  • 北京大学肿瘤医院(北京癌症医院):一家主要的学术中心,专注于胃肠癌、乳腺癌、淋巴瘤、黑色素瘤和肝胆肿瘤。以多学科团队、微创手术和国际合作而闻名。

  • 北京协和医院:中国排名最高的综合医院,适合罕见肿瘤、神经内分泌癌、老年患者或合并症患者。提供强大的遗传咨询和综合护理。

  • 私人和国际导向的选择:

  • 燕达国际医院:获得JCI认证,结合西方肿瘤学与传统中医的整体方法。
  • 北京博仁医院:在CAR-T疗法和血液癌症方面处于领先地位,提供优秀的英语支持和国际患者设施。
  • 北京阿瑞恩癌症医院:专注于先进放疗转诊和为外国人提供个性化服务。
  • 北京普华国际医院:因免疫疗法和微创治疗而受欢迎,流程简化。

公立医院通常处理高量的专业经验,而私立医院则优先考虑舒适和语言支持。

关键治疗能力

北京的医院提供全面的多学科护理:

  • 多学科团队(MDT):来自外科、医学肿瘤学、放射学、病理学和遗传学的专家共同协作制定个性化方案。
  • 精准医学:常规NGS基因测序和针对肺癌、乳腺癌、结直肠癌等癌症的靶向药物匹配。
  • 外科手术:机器人辅助手术(达芬奇)、腹腔镜手术和微创手术以加快恢复。
  • 化疗与靶向治疗:提供负担得起的国内选择,同时符合国际标准。
  • 免疫疗法:PD-1/PD-L1抑制剂及其组合用于晚期病例。
  • 先进放疗:IMRT、SBRT、质子和重离子治疗(对脑、脊柱和儿童肿瘤精准)。
  • CAR-T细胞疗法:广泛用于血癌;在专科中心对实体肿瘤逐渐可用。
  • 综合方法:传统中医用于管理副作用和支持恢复。
  • 临床试验:提供大量新疗法的机会,通常费用降低或免费。

国际患者的估计费用(美元,2026年)

费用因癌症类型、阶段、医院以及治疗是否为商业或试验性而异。国际患者通常自费或通过全球保险支付。以下是私人/国际部门自费的近似范围:

  • 初步评估与诊断:$2,000–$6,000(咨询、PET-CT、活检、基因检测)。
  • 手术:$5,000–$30,000+(标准到复杂/机器人辅助手术)。
  • 化疗:每周期$500–$3,000;完整疗程$5,000–$20,000。
  • 放疗:$5,000–$25,000(标准/先进);质子/重离子完整疗程$30,000–$60,000。
  • 靶向/免疫疗法:每月$2,000–$8,000;每年$25,000–$60,000。
  • CAR-T疗法:$60,000–$250,000(血癌$120,000–$170,000商业;在试验中更低)。
  • 按阶段总体费用:
  • 早期阶段(手术+辅助治疗):$7,000–$21,000。
  • 中期综合治疗:$21,000–$42,000。
  • 晚期/维持治疗(每年):$7,000–$21,000+。

住院费用每天增加$20–$500,具体取决于病房类型。北京的住宿费用范围从每晚$50–$150(酒店)到每月$800–$2,000(公寓)。临床试验可以大幅降低费用。

这些数字显著低于许多西方国家的同类护理,但始终建议请求个性化报价。

外国患者的实用建议

  • 收集并翻译医疗记录(扫描、病理、治疗历史)以便进行虚拟咨询。
  • 确保获得医院邀请函的医疗(S2)签证。
  • 选择拥有国际部门的医院,以获得更好的语言和后勤支持。
  • 预算额外费用,如翻译、旅行和生活费用。
  • 考虑保险覆盖或试验入组以管理费用。
  • 计划通过远程医疗进行后续跟进。

北京为许多国际患者提供高质量、创新的癌症护理,并具有实用优势。请直接咨询医院以获取最新信息和量身定制的计划。祝您在旅程中获得力量和积极的结果。

WhatsApp